双相心境障碍的药物治疗进展

Recent advances in treatment of drug for bipolar mood disorder drug therapy

双相心境障碍(BPD)是一种常见的精神障碍,临床的情感障碍中约50%是BPD,BPD的发作性、复发性特点尤为明显,长期的反复发作,导致患者疾病慢性化、人格改变和社会功能受损。加强双相心境障碍的药物治疗受到普遍重视。该疾病的药物治疗,除要求安全有效外,还需要不致促发情感转相,并能预防反复发作。本文就近年来临床上双相心境障碍药物治疗进展做一综述。

Bipolar mood disorder （ BPD ） is a common mental disorders , clinically the emotional disorders is about 50% for borderline personality disorder , particularly the onset , recurrent characteristics of BPD, long-term break out repeatedly , cause disease in patients with chronic , personality changes and social function is impaired .To strengthen the drug treatment of bipolar mood disorders is commonly .The drug treatment of the disease, in addition to the required is safe and effective , also need not trigger emotional phase inversion , and can prevent recurrent .In this paper , the recent advances in the treatment of bipolar mood disorder in clinical medicine are reviewed .